Hadassah

Hadassah Cures Mumbai Child of Thalassemia with Cutting-Edge Diagnosis

Thursday, Mar 26 2015

One day, Prof. Ariel Revel, head of the Ovum Donation and Fertility Preservation Program at the Hadassah Medical Center, was contacted by a professor from Mumbai, who had a one-year-old daughter with Thalassemia, an inherited blood disorder that threatened the quality of her life. Thanks to Hadassah’s state-of-the-art multi-stage intervention—including Pre-Implantation Genetic Diagnosis (PGD), In-vitro Fertilization (IVF), and a bone marrow transplant—that little girl is now Thalassemia-free.

Thalassemia, characterized by the abnormal formation of hemoglobin, is particularly found in people of Mediterranean origin and is prevalent in Israel. In Thalassemia major, the abnormality results in improper oxygen transport and the destruction of red blood cells, causing significant complications such as bone deformities and heart disease. In addition, sufferers often need blood transfusions on a regular basis, resulting in iron overload.

If a person is only a carrier of the disorder (having only one recessive gene for it), the result is mild anemia. If both parents carry the recessive gene, 25 percent of their children will be born with Thalassemia major.

A bone marrow transplant can change the composition of the blood and the fate of a child born with Thalassemia major. The bone marrow donor, however, needs to be close in age, race, and ethnicity to the child. In addition, the donor must have matching human leukocyte antigen (HLA), a particular aspect of the blood type. After researching world databases, the father was told his best option was to have another child, who would hopefully be healthy and a compatible donor for the sister.

Thanks to PGD, this medical intervention is possible. Through PGD, physicians can check the embryos to see if the child will be healthy and an HLA match. When an embryo meeting the qualifications is found, it is implanted into the uterus and the pregnancy proceeds as usual. There are only a few countries in the world that perform these diagnostic tests and Israel is one of them, Prof. Revel said. The Mumbai couple chose to come to Hadassah.

Following ovarian stimulation, Prof. Revel and his team removed 19 eggs from the mother and fertilized them. They examined all resulting embryos through PGD and found two that were an HLA match; however, one was thalassemic. The other, fortunately, was heterozygous for the gene, like the parents, and therefore had only Thalassemia minor. The doctors transferred the embryo to the patient's uterus and a normal pregnancy was launched.

Nine months later, a healthy baby boy was born. When he was one year old, his bone marrow was extracted for transplantation into his sister, making her a healthy three-year-old girl.

Prof. Revel was able to visit the family during a recent professional trip to India. “I had the pleasure of seeing for myself the fruits of our endeavors,” he said. “What a great feeling!”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More